StudyID: J-BAF 2009, atrial fibrillation, persistent
DISEASE INTERVENTION COMPARISON RESULTS
Circ J. 2009 Jun;73(6):1020-7 Randomized Controlled Trial
IN StudyID: J-BAF 2009, atrial fibrillation, persistent The Use of
bepridil
As Treatment, Chronic
Is worse Than
placebo
To modify outcomes at 3 months: higher cardioversion to SR with bepridil but high recurrence of AF and significant pro-arrhythmia